SCHEMBL280456

SCHEMBL280456

CC1NC(=O)OC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6230697 1.00
SCHEMBL16317106 1.00
SCHEMBL11248490 0.97
SCHEMBL24584756 0.72 TSHR (0.31)
SCHEMBL21940415 0.67 CYP2C19 (0.30)
SCHEMBL21939907 0.67 CYP2C19 (0.30)
SCHEMBL343560 0.67
SCHEMBL4652277 0.67 ABCB1 (0.32)
SCHEMBL25412343 0.67
SCHEMBL762450 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109837255-B Method for chemically modifying ketoamine oxidase 深圳市安帝宝科技有限公司 2023-03-14 CN claimed
US-20260077058-A1 PEPTIDE-TYPE NUCLEIC ACID CARRIER, GENE THERAPEUTIC COMPOSITION INCLUDING IT AND USE THEREOF UNIV NAT CHENG KUNG (TW) 2026-03-19 US disclosed
US-20250313594-A1 TWO-RESIDUE-EXTENDED PEPTIDE AND METHOD FOR PRODUCING SAME NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP) 2025-10-09 US disclosed
WO-2025070770-A1 COMPOUND HAVING OXAZOLIDINE STRUCTURE, NONAQUEOUS ELECTROLYTE CONTAINING SAID COMPOUND, AND NONAQUEOUS ELECTROLYTE BATTERY CONTAINING SAID NONAQUEOUS ELECTROLYTE セントラル硝子株式会社 2025-04-03 WO disclosed
EP-4527846-A1 TWO-RESIDUE-EXTENDED PEPTIDE AND METHOD FOR PRODUCING SAME NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP) 2025-03-26 EP disclosed
CN-118787635-A Dexmedetomidine multistage precise release control composition and application thereof 上海市第四人民医院 2024-10-18 CN disclosed
WO-2024213141-A1 DEXMEDETOMIDINE MULTI-STAGE PRECISE CONTROLLED-RELEASE COMPOSITION AND USE THEREOF 上海市第四人民医院 2024-10-17 WO disclosed
US-20240336734-A1 METHOD OF SYNTHESIZING A MUCIN AND PRODUCT THEREOF RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK 2024-10-10 US disclosed
CN-118459754-B Polyamino acid, preparation method thereof, hydrogel and chronic wound dressing 吉林大学 2024-10-08 CN disclosed
CN-118459754-A Polyamino acid, preparation method thereof, hydrogel and chronic wound dressing 吉林大学 2024-08-09 CN disclosed
EP-0617036-A2 Novel 2-thiosubstituted carbapenems AMERICAN CYANAMID COMPANY (US) 1994-09-28 EP disclosed
EP-0385999-B1 APPLICATION OF 4- 1-OXOALKYL]-2,5-OXAZOLIDINEDIONES IN SELECTIVE STEREOSPECIFIC FORMATION OF BIOLOGICALLY ACTIVE BETA-LACTAMS UNIV CINCINNATI (US) 1993-12-08 EP disclosed
US-5006661-A Selective stereospecific biologically active beta-lactams UNIVERSITY OF CINCINNATI (US) 1991-04-09 US disclosed
US-4970300-A CONJUGATE WITH LIGAND; LONGER HALF-LIFE NEW YORK UNIVERSITY (US) 1990-11-13 US disclosed
EP-0385999-A1 APPLICATION OF 4- 1-OXOALKYL]-2,5-OXAZOLIDINEDIONES IN SELECTIVE STEREOSPECIFIC FORMATION OF BIOLOGICALLY ACTIVE BETA-LACTAMS. UNIV CINCINNATI (US) 1990-09-12 EP disclosed
US-4855419-A Application of 4-[1-oxoalkyl]-2,5-oxazolidinediones in selective stereospecific formation of biologically active α-lactams UNIVERSITY OF CINCINNATI (US) 1989-08-08 US disclosed
WO-1988010256-A1 APPLICATION OF 4-[1-OXOALKYL]-2,5-OXAZOLIDINEDIONES IN SELECTIVE STEREOSPECIFIC FORMATION OF BIOLOGICALLY ACTIVE BETA-LACTAMS UNIVERSITY OF CINCINNATI (US) 1988-12-29 WO disclosed
EP-0153418-A1 MANDELIC ACID DERIVATIVES Kyoto Pharmaceutical Industries, Ltd. (JP) 1985-09-04 EP disclosed
US-4314023-A AZO-METHINE DYES KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1982-02-02 US disclosed
US-3962431-A Insecticidal use of O,O-dialkyl phosphorodithioate and phosphorothioate esters of oxazolidine-2,4-dione derivatives HERCULES INCORPORATED (US) 1976-06-08 US disclosed